Strandtx
Boston, US · Founded 2017 · 4 known investors
Strand is a clinical-stage biotechnology company developing programmable mRNA therapeutics for cancers and autoimmune diseases. The company has created an mRNA platform with cell-selective targeting capabilities to deliver therapeutic payloads within the body.
AI & Machine LearningBiotechMedical Devices
Founders & leadership
Strandtx was founded in 2017 by Jacob Becraft, Tasuku Kitada, Ron Weiss, and Darrell J. Irvine.
JB
Jacob BecraftCEO, Co-Founder
TK
Tasuku KitadaPresident, Head of R&D, Co-founder
RW
Ron WeissScientific Co-founder
DJ
Darrell J. IrvineScientific Co-founder
PN
Prashant NambiarChief Scientific Officer
EC
Ethan CashSenior Vice President, Head of Portfolio Management and Program Development
Board
JK
Jeb KeiperBoard of Directors
Investors · 4
Competitors · 3
by search overlap
Solu22 shared keywordsSolu Therapeutics is a clinical-stage biotech developing a class of antibody therapeutics that link bifunctional small molecules to proprietary effector antibodies (its CyTAC and TicTAC platforms) to reach cell surface targets like GPCRs and ion channels. Its pipeline targets oncology, immunology and inflammation, and pain, with a lead program in Phase 1 trials for chronic myelomonocytic leukemia.
Day One Biopharmaceuticals19 shared keywordsDay One is a biopharmaceutical company that develops first- or best-in-class targeted medicines for children and adults with life-threatening diseases, with a focus on cancers such as pediatric brain tumors. Founded in 2018, it received its first FDA approval in 2024 for a pediatric brain tumor treatment.
Transcode Therapeutics19 shared keywordsTransCode Therapeutics is a clinical-stage company developing immuno-oncology and RNA-based therapeutics for high-risk and advanced cancers. Its lead candidate, TTX-MC138, targets microRNA-10b to treat patients with metastatic cancer and is in Phase 2a clinical trials.
Companies competing with Strandtx for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Strandtx do?
- Strand is a clinical-stage biotechnology company developing programmable mRNA therapeutics for cancers and autoimmune diseases. The company has created an mRNA platform with cell-selective targeting capabilities to deliver therapeutic payloads within the body.
- Who founded Strandtx?
- Strandtx was founded by Jacob Becraft, Tasuku Kitada, Ron Weiss, Darrell J. Irvine in 2017.
- Who are Strandtx's investors?
- Strandtx's investors include Atinum Investment Co. Ltd., FPV, Playground Global, Starlight Ventures.
- Where is Strandtx headquartered?
- Strandtx is headquartered in Boston, US.